Bernhard Hirschel

Author PubWeight™ 12.70^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.	Clin Infect Dis	2011	4.31
2	Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid.	J Acquir Immune Defic Syndr	2013	2.38
3	Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.	Gut	2010	1.53
4	Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection.	J Virol	2003	1.18
5	Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts.	Antivir Ther	2002	1.05
6	Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy.	J Infect Dis	2004	0.98
7	Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures.	J Acquir Immune Defic Syndr	2010	0.87
8	Treatment interruption for convenience, cost cutting and toxicity sparing.	Curr Opin HIV AIDS	2007	0.77